Cargando…

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma

Multiple myeloma (MM) is a hematological malignancy, which remains incurable because most patients eventually relapse or become refractory to current treatments. Due to heterogeneity within the cancer cell microenvironment, cancer cell populations employ a dynamic survival strategy to chemotherapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Issa, Mark E., Takhsha, Farnaz Sedigheh, Chirumamilla, Chandra Sekhar, Perez-Novo, Claudina, Vanden Berghe, Wim, Cuendet, Muriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303245/ https://www.ncbi.nlm.nih.gov/pubmed/28203307 http://dx.doi.org/10.1186/s13148-017-0319-5

Ejemplares similares

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
por: Theys, Claudia, et al.
Publicado: (2022)

Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells
por: Logie, Emilie, et al.
Publicado: (2021)

The steroidal lactone withaferin A impedes T-cell motility by inhibiting the kinase ZAP70 and subsequent kinome signaling
por: Fazil, Mobashar Hussain Urf Turabe, et al.
Publicado: (2021)

The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs
por: Coira, Isabel F., et al.
Publicado: (2022)

Covalent Cysteine Targeting of Bruton’s Tyrosine Kinase (BTK) Family by Withaferin-A Reduces Survival of Glucocorticoid-Resistant Multiple Myeloma MM1 Cells
por: Logie, Emilie, et al.
Publicado: (2021)

Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences
por: Declerck, Ken, et al.
Publicado: (2021)

Ectopic MicroRNA-150-5p Transcription Sensitizes Glucocorticoid Therapy Response in MM1S Multiple Myeloma Cells but Fails to Overcome Hormone Therapy Resistance in MM1R Cells
por: Palagani, Ajay, et al.
Publicado: (2014)

Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells
por: Issa, Mark E., et al.
Publicado: (2017)

Peptides as epigenetic modulators: therapeutic implications
por: Janssens, Yorick, et al.
Publicado: (2019)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023)

Nasal Polyp-Derived Mesenchymal Stromal Cells Exhibit Lack of Immune-Associated Molecules and High Levels of Stem/Progenitor Cells Markers
por: de Oliveira, Pedro Wey Barbosa, et al.
Publicado: (2017)

“HLA-C: evolution, epigenetics, and pathological implications in the major histocompatibility complex”
por: Velastegui, Erick, et al.
Publicado: (2023)

From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?
por: vel Szic, Katarzyna Szarc, et al.
Publicado: (2015)

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma
por: Takhsha, Farnaz Sedigheh, et al.
Publicado: (2021)

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
por: vel Szic, Katarzyna Szarc, et al.
Publicado: (2017)

Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
por: Simoes-Pires, Claudia, et al.
Publicado: (2014)

Tackling Chronic Inflammation with Withanolide Phytochemicals—A Withaferin A Perspective
por: Logie, Emilie, et al.
Publicado: (2020)

Characterization of Blood Surrogate Immune-Methylation Biomarkers for Immune Cell Infiltration in Chronic Inflammaging Disorders
por: Declerck, Ken, et al.
Publicado: (2019)

Metabolic syndrome: Nutri-epigenetic cause or consequence?
por: Silva-Ochoa, Alfonso D., et al.
Publicado: (2023)

MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
por: Rahman, Mohammad Mijanur, et al.
Publicado: (2019)

Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applications
por: Spaleniak, Weronika, et al.
Publicado: (2023)

The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma
por: Rasche, Leo, et al.
Publicado: (2019)

LC-MS Characterization and Biological Activities of Cuban Cultivars of Plectranthus neochilus Schltr
por: Rodríguez-Ferreiro, Annarli O., et al.
Publicado: (2022)

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model
por: Freire Boullosa, Laurie, et al.
Publicado: (2022)

Emerging immune and cell death mechanisms in stroke: Saponins as therapeutic candidates
por: García-Pupo, Laura, et al.
Publicado: (2020)

Epigenetic Aberrations in Multiple Myeloma
por: Caprio, Cinzia, et al.
Publicado: (2020)

Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence
por: Logie, Emilie, et al.
Publicado: (2021)

Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis
por: Pérez-Novo, Claudina Angela, et al.
Publicado: (2006)

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer
por: Sayar, Erolcan, et al.
Publicado: (2023)

Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism
por: Rodriguez-Gonzalez, Julio César, et al.
Publicado: (2021)

Implications of Heterogeneity in Multiple Myeloma
por: de Mel, Sanjay, et al.
Publicado: (2014)

Distinct promoter methylation profile reveals spatial epigenetic heterogeneity in 2 myeloma patients with multifocal extramedullary relapses
por: Yao, Qiumei, et al.
Publicado: (2018)

Epigenetic heterogeneity in cancer
por: Guo, Mingzhou, et al.
Publicado: (2019)

The role of epigenetics in the biology of multiple myeloma
por: Dimopoulos, K, et al.
Publicado: (2014)

A systems biology network analysis of nutri(epi)genomic changes in endothelial cells exposed to epicatechin metabolites
por: Milenkovic, Dragan, et al.
Publicado: (2018)

Staphylococcus aureus and Chronic Airway Disease
por: Derycke, Lara, et al.
Publicado: (2010)

Caspases leave the beaten track: caspase-mediated activation of NF-κB
por: Lamkanfi, Mohamed, et al.
Publicado: (2006)

Mining the human proteome for conserved mechanisms
por: Naulaerts, Stefan, et al.
Publicado: (2015)

International mobility, sexual behaviour and HIV-related characteristics of men who have sex with men residing in Belgium
por: Vanden Berghe, Wim, et al.
Publicado: (2013)

Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance
por: Ge, Maolin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3leudhbnrdd67r57nbn244v9um